These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17847177)

  • 41. Pharmacoeconomics--an aid to better decision-making.
    Arenas-Guzman R; Tosti A; Hay R; Haneke E;
    J Eur Acad Dermatol Venereol; 2005 Sep; 19 Suppl 1():34-9. PubMed ID: 16120204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacoeconomics: disease-based management applications.
    Garrelts JC
    Pharm Pract Manag Q; 1996 Jul; 16(2):36-40. PubMed ID: 10161609
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacy costs associated with nonformulary drug requests.
    Sweet BV; Stevenson JG
    Am J Health Syst Pharm; 2001 Sep; 58(18):1746-52. PubMed ID: 11571818
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The pharmacoeconomics of acne treatment: where are we heading?
    Inglese MJ; Fleischer AB; Feldman SR; Balkrishnan R
    J Dermatolog Treat; 2008; 19(1):27-37. PubMed ID: 18273722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of pharmacoeconomics to formulary decision making in managed care organizations.
    Suh DC; Okpara IR; Agnese WB; Toscani M
    Am J Manag Care; 2002 Feb; 8(2):161-9. PubMed ID: 11858228
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Where does high-quality research in economic evaluation come from?
    Zhang JX
    Pharmacotherapy; 2009 Jan; 29(1):1-2. PubMed ID: 19113791
    [No Abstract]   [Full Text] [Related]  

  • 47. Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital.
    Woodward RS; Medoff G; Smith MD; Gray JL
    Am J Med; 1987 Nov; 83(5):817-23. PubMed ID: 3674089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of centrally developed pharmacoeconomic assessments for local formulary decisions.
    Tordoff JM; Murphy JE; Norris PT; Reith DM
    Am J Health Syst Pharm; 2006 Sep; 63(17):1613-8. PubMed ID: 16914631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibiotic therapy intervention at a community hospital. Opportunities for cost and quality improvements.
    Thrasher CM; Stefl ME; Dorner FH
    Hosp Top; 1995; 73(2):12-5. PubMed ID: 10144621
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparative pharmacoeconomic evaluation of various approaches to antibacterial therapy of ventilator-associated pneumonia].
    Rudnov VA
    Antibiot Khimioter; 2001; 46(12):22-6. PubMed ID: 12108089
    [No Abstract]   [Full Text] [Related]  

  • 51. Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost.
    Climo MW; Israel DS; Wong ES; Williams D; Coudron P; Markowitz SM
    Ann Intern Med; 1998 Jun; 128(12 Pt 1):989-95. PubMed ID: 9625685
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Interventions by clinical pharmacists on surgical wards - impact on antibiotic therapy].
    Weber A; Schneider C; Grill E; Strobl R; Vetter-Kerkhoff C; Jauch KW
    Zentralbl Chir; 2011 Feb; 136(1):66-73. PubMed ID: 21337293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pharmacoeconomics of infection in the intensive care unit].
    Grau S; Alvarez-Lerma F
    Rev Esp Quimioter; 2008; 21 Spec No 1():26-34. PubMed ID: 18752077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antimicrobial stewardship: optimizing antibiotic use in an era of increasing resistance and rising costs.
    Pile JC
    J Hosp Med; 2011 Jan; 6 Suppl 1():S1-3. PubMed ID: 21225945
    [No Abstract]   [Full Text] [Related]  

  • 55. Hospital pharmacy decisions, cost containment, and the use of cost-effectiveness analysis.
    Sloan FA; Whetten-Goldstein K; Wilson A
    Soc Sci Med; 1997 Aug; 45(4):523-33. PubMed ID: 9226778
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hospital-based strategies for combating resistance.
    Owens RC; Rice L
    Clin Infect Dis; 2006 Apr; 42 Suppl 4():S173-81. PubMed ID: 16544268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of antibiotic order form guiding rational use of expensive drugs on cost containment.
    Sirinavin S; Suvanakoot P; Sathapatayavongs B; Malatham K
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):636-42. PubMed ID: 10437971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Formulary management as a tool to improve medication use and gain physician support.
    Lehmann DF; Guharoy R; Page N; Hirschman K; Ploutz-Snyder R; Medicis J
    Am J Health Syst Pharm; 2007 Mar; 64(5):464-6. PubMed ID: 17322158
    [No Abstract]   [Full Text] [Related]  

  • 59. Improving patient care and pharmacy management: the effect of hospital formularies.
    Plumridge RJ; Stoelwinder JU; Berbatis CG
    Drug Intell Clin Pharm; 1984; 18(7-8):652-6. PubMed ID: 6430662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of decision analysis in antibiotic formulary choices.
    Szymusiak-Mutnick B; Mutnick AH
    J Pharm Technol; 1994; 10(1):23-6. PubMed ID: 10133008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.